Search Results

Filter
  • 1-10 of  15 results for ""Angiotensin II Type 1 Receptor Blockers""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Baseline Characteristics of the VANISH Cohort.

  • Authors : Axelsson Raja A; Copenhagen University Hospital Rigshospitalet, Denmark (A.A.R., H.B.).; Shi L

Subjects: Mutation*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Cardiomyopathy, Hypertrophic/Cardiomyopathy, Hypertrophic/Cardiomyopathy, Hypertrophic/*drug therapy

  • Source: Circulation. Heart failure [Circ Heart Fail] 2019 Dec; Vol. 12 (12), pp. e006231. Date of Electronic Publication: 2019 Dec 09.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101479941 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.

  • Authors : Rodrigues CIS; Pontifícia Universidade Católica de São Paulo, Faculdade de Ciências Médicas e da Saúde, São Paulo, SP, Brazil.; Sociedade Brasileira de Nefrologia, Departamento de Hipertensão, São Paulo, SP, Brazil.

Subjects: Betacoronavirus*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*therapeutic use

  • Source: Jornal brasileiro de nefrologia [J Bras Nefrol] 2020 Aug 26; Vol. 42 (2 suppl 1), pp. 47-48.Publisher: Sociedade Brasileira de Nefrologia Country of Publication: Brazil NLM ID: 9426946 Publication Model: Print Cited

Record details

×
Academic Journal

A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.

  • Authors : Fuchs FD; Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. ; Fuchs SC

Subjects: Research Design*; Amiloride/Amiloride/Amiloride/*therapeutic use ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use

  • Source: Trials [Trials] 2011 Feb 24; Vol. 12, pp. 53. Date of Electronic Publication: 2011 Feb 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Academic Journal

Gastrointestinal Manifestations and Associated Health Outcomes of COVID-19: A Brazilian Experience From the Largest South American Public Hospital.

  • Authors : Moura DTH; Hospital das Clinicas (HCFMUSP), Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil.; Brigham and Women's Hospital - Harvard Medical School, Boston 02115, MA, United States.

Subjects: Angiotensin Receptor Antagonists* ; Coronavirus Infections* ; Pandemics*

  • Source: Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2020 Oct 26; Vol. 75, pp. e2271. Date of Electronic Publication: 2020 Oct 26 (Print Publication:Publisher: Elsevier Country of Publication: United States NLM ID: 101244734 Publication Model: eCollection Cited Medium: Internet ISSN: 1980-5322

Record details

×
Academic Journal

Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.

  • Authors : Cestário EDES; Hypertension Clinic, Department of Internal Medicine, State Medical School of São José do Rio Preto (FAMERP), Rua Tocantins 2971 Votuporanga, São Paulo, CEP 15505-188, Brazil. .; Fernandes LAB

Subjects: Adrenergic beta-1 Receptor Antagonists/Adrenergic beta-1 Receptor Antagonists/Adrenergic beta-1 Receptor Antagonists/*therapeutic use ; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*therapeutic use

  • Source: Trials [Trials] 2018 Feb 12; Vol. 19 (1), pp. 101. Date of Electronic Publication: 2018 Feb 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Academic Journal

Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.

  • Authors : Monteiro MA; National Institute for Quality Control in Health, Oswaldo Cruz Foundation (INCQS/Fiocruz), Rio de Janeiro, RJ, Brazil. Electronic address: .; de Lima PC

Subjects: Nitrosamines*/Nitrosamines*/Nitrosamines*/analysis; Humans ; Angiotensin II Type 1 Receptor Blockers

  • Source: Journal of pharmaceutical sciences [J Pharm Sci] 2023 May; Vol. 112 (5), pp. 1305-1314. Date of Electronic Publication: 2023 Jan 16.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Resistant hypertension optimal treatment trial: a randomized controlled trial.

Subjects: Drug Resistance* ; Research Design*; Adrenergic alpha-2 Receptor Agonists/Adrenergic alpha-2 Receptor Agonists/Adrenergic alpha-2 Receptor Agonists/*therapeutic use

  • Source: Clinical cardiology [Clin Cardiol] 2014 Jan; Vol. 37 (1), pp. 1-6. Date of Electronic Publication: 2013 Dec 11.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 7903272 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

FGF-23 as a predictor of renal outcome in diabetic nephropathy.

  • Authors : Titan SM; Sao Paulo University Medical School, Av Dr Enéas de Carvalho Aguiar, 255, Nephrology Department, 05403-000, São Paulo, SP, Brazil. ; Zatz R

Subjects: Albuminuria/Albuminuria/Albuminuria/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Diabetic Nephropathies/Diabetic Nephropathies/Diabetic Nephropathies/*blood

  • Source: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2011 Feb; Vol. 6 (2), pp. 241-7. Date of Electronic Publication: 2010 Oct 21.Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  15 results for ""Angiotensin II Type 1 Receptor Blockers""